Role of Protein Kinase C in Cd47-Mediated Phosphatidylserine Expression Pathway by Bric 126 in Leukaemia Cell Line
Ikenna Kingsley Uchendu*
Corresponding Author: Ikenna Kingsley Uchendu* and Ogechukwu C Dozie-Nwakile
Accepted: February 25, 2021 Available Online: March 15, 2021
Citation: Uchendu IK. (2021) Role of Protein Kinase C in Cd47-Mediated Phosphatidylserine Expression Pathway by Bric 126 in Leukaemia Cell Line. BioMed Res J, S(1): 04.
Copyrights: ©2021 Uchendu IK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
Treatment failure in T-cell acute lymphoblastic leukaemia (T-ALL) occurs when leukemic blasts acquire resistance to chemotherapeutic agents. Current research efforts are focused on the search for targets for the development of more effective and less toxic anti-leukemic drugs. CD47 has been suggested to be involved in chemo-resistance and cell metastasis. Although several potential mechanisms were suggested to explain the therapeutic effect of CD47-targeting; the downstream effectors which lead to different effects by CD47 are still not well understood. In this study, the role of Protein kinase C (PKC) in CD47-mediated phosphatidylserine (PS) expression pathway in jurkat T cells was investigated. Jurkat T cells were incubated with anti-CD47 mAb (BRIC 126), anti-CD44 mAb (BRIC 235) or control in the presence or absence of Bisindolylmaleimide I, hydrochloride (PKC inhibitor). Cells were stained with annexin-V FITC. Flow cytometry analysis was used for measurement of fluorescence intensity. Cell viability was detected using trypan blue exclusion test. PKC inhibition enhanced phosphatidylserine expression in CD47 receptor-mediated leukaemia cells apoptotic pathway. This indicates that PKC may be involved in CD47-mediated PS exposure pathway in jurkat T cells. The observations from this study identify CD47 and PKC as novel functional proteins in jurkat T cells with promising therapeutic potential. This study would provide insight for targeted therapy against T-ALL disease.

 Keywords: Jurkat T-cell, Acute lymphoblastic leukaemia, CD47, PKC, Phosphatidylserine, Apoptotosis, Flow cytometry